Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions
Joint Authors
Hough, Bruce
Lentzsch, Suzanne
Brufsky, Adam
Source
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-03-07
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
We report a case of a female with stage I infiltrating ductal carcinoma who received adjuvant therapy including trastuzumab.
One year later she developed lytic lesions and was retreated with trastuzumab that was held after she developed symptomatic heart failure.
Lytic lesions were attributed to relapse of breast cancer, and cardiac failure attributed to prior trastuzumab therapy.
After complications necessitated multiple hospitalizations, a further workup revealed that the lytic lesions were not metastatic breast cancer but multiple myeloma.
Her advanced multiple myeloma was associated with systemic amyloidosis involving gut and heart, which ultimately led to her demise.
This report addresses the pitfalls of overlapping symptoms and the question of which patients with suspected metastatic disease should undergo a biopsy.
American Psychological Association (APA)
Hough, Bruce& Brufsky, Adam& Lentzsch, Suzanne. 2010. Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions. Journal of Oncology،Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-477329
Modern Language Association (MLA)
Hough, Bruce…[et al.]. Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions. Journal of Oncology No. 2010 (2010), pp.1-3.
https://search.emarefa.net/detail/BIM-477329
American Medical Association (AMA)
Hough, Bruce& Brufsky, Adam& Lentzsch, Suzanne. Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions. Journal of Oncology. 2010. Vol. 2010, no. 2010, pp.1-3.
https://search.emarefa.net/detail/BIM-477329
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-477329